C-Phycocyanin–Cisplatin Combination Targeting Redox Balance for Enhanced Efficacy Against Glioblastoma Cells
Rym Akrout, Ludovic Leloup, Khouloud Ayed, Fabrice Parat, Sami Zekri, Wassim Y. Almawi, Rahma Boughriba, Hanen Attia, Olfa Masmoudi-Kouki, Hervé Kovacic, Asma Gati · 2025
Read C-Phycocyanin–Cisplatin Combination Targeting Redox Balance for Enhanced Efficacy Against Glioblastoma Cells by Rym Akrout, Ludovic Leloup, Khouloud Ayed, Fabrice Parat, Sami Zekri, Wassim Y. Almawi, Rahma Boughriba, Hanen Attia, Olfa Masmoudi-Kouki, Hervé Kovacic, Asma Gati (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12712674.txt.
Description
Akrout and a large team pair an algae pigment with a classic cancer drug against brain tumor cells in twenty twenty-five. The drug, cisplatin, fights glioblastoma poorly in the brain and harms the body. The pigment may rebalance cell redox stress and aid killing. Two tumor cell lines were dosed with each agent alone and together.
In the drug sensitive line, the pair cut survival far below the drug alone. Death markers and DNA breaks rose while stress signals fell. Protective enzymes rose as well. In a resistant line, the pigment alone beat the pair. The pigment may serve alone where the drug fails, they suggest.
Catalog record
| CREATOR | Rym Akrout, Ludovic Leloup, Khouloud Ayed, Fabrice Parat, Sami Zekri, Wassim Y. Almawi, Rahma Boughriba, Hanen Attia, Olfa Masmoudi-Kouki, Hervé Kovacic, Asma Gati |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |